2 213

Cited 12 times in

The role of F-18-fluorodeoxyglucose positron emission tomography in the diagnosis, staging, and follow-up of cholangiocarcinoma

DC FieldValueLanguage
dc.contributor.author문창모-
dc.contributor.author방승민-
dc.contributor.author정재복-
dc.date.accessioned2014-12-20T16:50:39Z-
dc.date.available2014-12-20T16:50:39Z-
dc.date.issued2011-
dc.identifier.issn0960-7404-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/93484-
dc.description.abstract(18)F-Fluorodeoxyglucose positron emission tomography ((18)FDG-PET) is a new diagnostic technique for the diagnosis and staging of cholangiocarcinoma. For diagnosis of a primary cholangiocarcinoma, (18)FDG-PET seems to be helpful to discriminate between malignant and benign lesions. However, the accuracy of (18)FDG-PET seems to be dependent on the anatomic location, growth pattern, and pathologic characteristics of the lesion. It has been proved that the accuracy of (18)FDG-PET is limited to detection of extrahepatic, infiltrating, and mucinous cholangiocarcinomas. Due to its lower sensitivity, (18)FDG-PET provides complementary rather than confirmative information in the diagnosis of regional lymph node metastasis. In contrast, it has high accuracy in detecting unsuspected distant metastases. The role of (18)FDG-PET in detecting cancer recurrence, monitoring treatment response, and predicting prognosis is still controversial.-
dc.description.statementOfResponsibilityopen-
dc.relation.isPartOfSURGICAL ONCOLOGY-OXFORD-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.titleThe role of F-18-fluorodeoxyglucose positron emission tomography in the diagnosis, staging, and follow-up of cholangiocarcinoma-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학)-
dc.contributor.googleauthorChang Mo Moon-
dc.contributor.googleauthorSeungmin Bang-
dc.contributor.googleauthorJae Bock Chung-
dc.identifier.doi10.1016/j.suronc.2009.08.003-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA01390-
dc.contributor.localIdA01786-
dc.contributor.localIdA03706-
dc.relation.journalcodeJ02709-
dc.identifier.eissn1879-3320-
dc.identifier.urlhttp://www.sciencedirect.com/science/article/pii/S0960740409001029-
dc.contributor.alternativeNameMoon, Chang Mo-
dc.contributor.alternativeNameBang, Seung Min-
dc.contributor.alternativeNameChung, Jae Bock-
dc.contributor.affiliatedAuthorMoon, Chang Mo-
dc.contributor.affiliatedAuthorBang, Seung Min-
dc.contributor.affiliatedAuthorChung, Jae Bock-
dc.rights.accessRightsnot free-
dc.citation.volume20-
dc.citation.number1-
dc.citation.startPage10-
dc.citation.endPage17-
dc.identifier.bibliographicCitationSURGICAL ONCOLOGY-OXFORD, Vol.20(1) : 10-17, 2011-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.